Cointime

Gel-E

company

About

developed an advanced wound care platform designed to be used across a broad spectrum of clinical.

  • 11 - 50

Highlights

Total Funding Amount
$0.97M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.97M
Industries
Biotechnology,Health Care,Life Science,Medical
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

gel-e Life Sciences has developed an advanced wound care platform that can be used across a broad spectrum of clinical and non-clinical settings. By making molecular modifications to natural biopolymers, gel-e’s patented approach provides rapid hemostasis in a clean, safe healing environment. Using non-dilutive grant funding, the company has achieved milestones such as 1 FDA Clearance, 5 issued patents, and 6 peer-reviewed publications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$0.97M
Gel-E has raised a total of $0.97M in funding over 2 rounds. Their latest funding was raised on Jan 18, 2013 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 18, 2013 Grant $0.97M 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Gel-E is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
Содержание
компания